valproic acid and transforming growth factor beta

valproic acid has been researched along with transforming growth factor beta in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's7 (63.64)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Althoen, MC; Cotman, CW; Loo, DT1
Chung, YL; Wang, AJ; Yao, LF1
Bae, YC; Cho, HH; Jung, JS; Kim, YJ; Park, HT; Suh, KT1
Cheng, L; Guan, W; Hu, W; Pei, G; Qiu, B; Wang, M; Yang, W; Yu, Y; Zhao, J1
Aoyagi, Y; Fujimaki, S; Hirose, Y; Kobayashi, T; Kubota, M; Matsuda, Y; Osawa, M; Sakata, J; Takamura, M; Wakai, T; Yamagiwa, S1
Cheng, L; Gao, L; Guan, W; Hu, W; Mao, J; Pei, G; Qiu, B; Yu, Y; Zhao, J1
Aragone, DDSP; Costalonga, EC; de Freitas, LJ; Noronha, IL; Silva, FMO1
Chen, Y; Jiang, W; Jin, X; Lan, X; Lu, G; Mao, S; Xia, Q; Yuan, C1
Gad, AM1
Lu, G; Qi, G; Wang, C; Xia, Q; Yu, J; Zhang, H; Zhao, Y1
Brenner, W; Butter, F; Kiweler, N; Krämer, OH; Mahendrarajah, N; Schneider, G; Stauber, RH; Wirth, M; Wünsch, D1

Other Studies

11 other study(ies) available for valproic acid and transforming growth factor beta

ArticleYear
Differentiation of serum-free mouse embryo cells into astrocytes is accompanied by induction of glutamine synthetase activity.
    Journal of neuroscience research, 1995, Oct-01, Volume: 42, Issue:2

    Topics: Animals; Astrocytes; Biomarkers; Blood; Blotting, Western; Brain; Bucladesine; Cattle; Cell Differentiation; Charcoal; Culture Media, Serum-Free; Enzyme Induction; Gene Expression Regulation, Developmental; Glutamate-Ammonia Ligase; Hydrocortisone; Intermediate Filament Proteins; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; Nestin; Stem Cells; Transforming Growth Factor beta; Tretinoin; Valproic Acid

1995
Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:3

    Topics: Acetylation; Animals; Antineoplastic Agents; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Enzyme Inhibitors; Female; Fibrosis; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Immunohistochemistry; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Phenylbutyrates; Radiation Injuries; Radiotherapy; Rats; Rats, Sprague-Dawley; Ribonucleases; Skin; Time Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Valproic Acid; Wound Healing

2004
Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
    Journal of cellular biochemistry, 2005, Oct-15, Volume: 96, Issue:3

    Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Carrier Proteins; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Mesenchymal Stem Cells; Osteogenesis; Osteopontin; Sialoglycoproteins; Sp7 Transcription Factor; Transcription Factors; Transforming Growth Factor beta; Valproic Acid

2005
Generation of neural progenitor cells by chemical cocktails and hypoxia.
    Cell research, 2014, Volume: 24, Issue:6

    Topics: Animals; Cell Hypoxia; Cell Lineage; Cell Proliferation; Cells, Cultured; Cluster Analysis; Enzyme Inhibitors; Gene Expression Profiling; Glycogen Synthase Kinase 3; Histone Demethylases; Humans; Mice; Mice, Inbred C57BL; Neural Stem Cells; Pyrazoles; Pyridines; Pyrimidines; Transcriptome; Transforming Growth Factor beta; Valproic Acid

2014
Valproic acid overcomes transforming growth factor-β-mediated sorafenib resistance in hepatocellular carcinoma.
    International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Liver Neoplasms; MAP Kinase Signaling System; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib; Transforming Growth Factor beta; Treatment Failure; Treatment Outcome; Valproic Acid

2014
Direct conversion of astrocytes into neuronal cells by drug cocktail.
    Cell research, 2015, Volume: 25, Issue:11

    Topics: Animals; Anticonvulsants; Astrocytes; Gene Expression; Glycogen Synthase Kinase 3; Humans; Mice; Neurons; Pyrazoles; Pyridines; Pyrimidines; Transforming Growth Factor beta; Valproic Acid

2015
Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
    PloS one, 2017, Volume: 12, Issue:9

    Topics: Animals; Biological Transport; Biomarkers; Body Weight; Bone Morphogenetic Protein 7; Calcium-Binding Proteins; Capillaries; Cell Count; Cytokines; Fibronectins; Gene Expression Regulation; Inflammation; Inflammation Mediators; Male; Myofibroblasts; Neovascularization, Physiologic; Peritoneal Fibrosis; Peritoneum; Rats, Wistar; RNA, Messenger; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Treatment Outcome; Valproic Acid; Vascular Endothelial Growth Factor A

2017
Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.
    Molecular medicine reports, 2017, Volume: 16, Issue:5

    Topics: Cadherins; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Intracellular Signaling Peptides and Proteins; Kidney Neoplasms; Middle Aged; RNA, Messenger; Smad4 Protein; Transforming Growth Factor beta; Up-Regulation; Valproic Acid; Vimentin

2017
Study on the influence of caffeic acid against sodium valproate-induced nephrotoxicity in rats.
    Journal of biochemical and molecular toxicology, 2018, Volume: 32, Issue:8

    Topics: Animals; Anticonvulsants; Biomarkers; Caffeic Acids; Caspase 3; Creatinine; Inflammation; Interferon-gamma; Kidney; Male; Malondialdehyde; NF-kappa B; Nitric Oxide Synthase Type II; Rats, Sprague-Dawley; Receptors, Notch; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Urea; Valproic Acid

2018
Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
    European journal of pharmacology, 2019, Oct-05, Volume: 860

    Topics: Animals; Cell Proliferation; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neoplasm Metastasis; PC-3 Cells; Prostatic Neoplasms; Signal Transduction; Smad Proteins; Transcription Factors; Transforming Growth Factor beta; Up-Regulation; Valproic Acid; Xenograft Model Antitumor Assays

2019
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes.
    Journal of cancer research and clinical oncology, 2020, Volume: 146, Issue:2

    Topics: Animals; Benzamides; Cell Plasticity; Cisplatin; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Drug Resistance, Neoplasm; Histone Deacetylase Inhibitors; Humans; Hydroxyurea; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms; Pyridines; Transforming Growth Factor beta; Valproic Acid

2020